Yes, losing your sense of smell can be an early warning sign of brain changes—particularly those associated with neurodegenerative diseases. A growing body of medical research shows that unexplained olfactory dysfunction often precedes cognitive decline and motor symptoms by several years, making it a potentially valuable indicator for early detection of conditions like Parkinson’s disease and Alzheimer’s disease. When someone loses the ability to smell without an obvious cause like a head cold or nasal polyp, their brain’s olfactory system—the neural pathways that process smell—may already be experiencing damage from pathological protein accumulation. The olfactory system is remarkably vulnerable to the same proteins that damage other brain regions in neurodegenerative disease.
The olfactory bulb, located just above the nasal cavity and responsible for processing smell signals, sits at the brain’s interface with the outside world and appears to be one of the first regions where pathogenic alpha-synuclein (in Parkinson’s) and amyloid-beta and tau (in Alzheimer’s) accumulate. This makes smell loss a potential early biomarker—an observable sign that cellular damage has already begun. For someone experiencing unexplained smell loss alongside other subtle changes like mood shifts, constipation, sleep disturbances, or difficulty with balance, medical evaluation is warranted. While smell loss alone does not diagnose brain disease, it may be part of a constellation of early symptoms that deserve investigation.
Table of Contents
- What Role Does the Olfactory System Play in Detecting Brain Changes?
- How Common Is Olfactory Loss as an Early Symptom?
- What Is the Connection Between Olfactory Loss and Specific Brain Diseases?
- How Can Smell Loss Be Evaluated in Clinical Practice?
- What Other Brain Changes Often Accompany Early Olfactory Loss?
- What Is the Timeline Between Olfactory Loss and Noticeable Symptoms?
- When Should Someone Seek Medical Evaluation for Smell Loss?
- Frequently Asked Questions
What Role Does the Olfactory System Play in Detecting Brain Changes?
The olfactory system connects directly to the brain’s limbic system—areas responsible for memory, emotion, and autonomic functions—making it a window into deeper neurological processes. The olfactory bulb and related structures are among the few places in the adult brain where neurons continue to regenerate, yet they are also uniquely exposed to environmental pathogens and accumulating proteins. Neuroscientists have found that the olfactory epithelium (tissue lining the nasal cavity) and the olfactory bulb show pathological changes in both Parkinson’s disease and Alzheimer’s disease decades before symptoms typically appear.
Research using autopsy data and imaging studies shows that alpha-synuclein pathology in Parkinson’s disease often begins in the olfactory bulb and related brainstem structures before spreading to motor control regions. Similarly, tau tangles and amyloid plaques associated with Alzheimer’s can be detected in olfactory structures in individuals who show no cognitive symptoms yet. A study following people over time found that those who experienced smell loss and scored lower on olfactory identification tests had a higher risk of developing cognitive impairment within 5 to 10 years, even when initial cognitive testing appeared normal.
How Common Is Olfactory Loss as an Early Symptom?
Smell loss is far more prevalent in people with Parkinson’s disease and Alzheimer’s than in the general aging population. Approximately 70 to 90 percent of people with Parkinson’s disease experience hyposmia (reduced sense of smell) or anosmia (complete loss of smell), often years before the classic motor symptoms like tremor or rigidity appear. In Alzheimer’s disease, studies report smell dysfunction in 40 to 80 percent of patients, depending on disease stage and the specific test used.
However, smell loss is also common in normal aging and in many other conditions—sinus disease, upper respiratory infections, nutritional deficiencies, and smoking all affect olfaction. This is a crucial limitation: most people who lose their sense of smell do not go on to develop a neurodegenerative disease. The clinical significance of smell loss depends on its pattern (sudden versus gradual), whether it occurs alongside other unexplained symptoms, and individual risk factors like family history or age of onset. A 35-year-old with progressive smell loss and early balance problems warrants different clinical attention than an 85-year-old with smell loss following a sinus infection.
What Is the Connection Between Olfactory Loss and Specific Brain Diseases?
Parkinson’s disease shows the strongest association with smell dysfunction. The condition involves accumulation of alpha-synuclein in dopamine-producing neurons, and this same pathology affects olfactory neurons early on. An individual might notice they no longer smell their morning coffee or cannot detect the scent of flowers at a level that was normal before—sometimes years before developing a resting tremor or gait disturbance.
Some research suggests that smell dysfunction may actually be a better early biomarker for Parkinson’s than current motor tests, because the pathology reaches the olfactory system so early. In Alzheimer’s disease, the connection is more variable, partly because Alzheimer’s pathology spreads through the brain along connected neural networks rather than starting from a single region. However, individuals with genetic risk factors for Alzheimer’s (particularly APOE4 carriers) show higher rates of smell dysfunction even before cognitive decline becomes apparent. Lewy body dementia, which shares pathology with Parkinson’s disease, also commonly presents with early smell loss alongside visual hallucinations and sleep disturbances.
How Can Smell Loss Be Evaluated in Clinical Practice?
A clinician evaluating unexplained smell loss typically begins with history-taking to rule out recent infections, head injury, medication changes, or nasal obstruction. The most common standardized test is the University of Pennsylvania Smell Identification Test (UPSIT), which involves scratch-and-sniff cards with 40 common odors; patients rank their best guess among four options. This test is more reliable than asking someone to smell a coffee cup or lemon, which can be influenced by memory or expectation.
Olfactory testing has both advantages and limitations in a clinical setting. The advantage is that it’s non-invasive, inexpensive, and can detect dysfunction earlier than clinical symptoms become obvious. The limitation is that smell tests are not specific to any single disease—a low score on the UPSIT could indicate Parkinson’s disease, Alzheimer’s disease, head trauma, sinusitis, or other causes. For this reason, smell testing is most useful when combined with other clinical information: family history, the presence of other early symptoms (constipation, REM sleep behavior disorder, subtle balance changes in Parkinson’s cases), cognitive screening, or imaging studies.
What Other Brain Changes Often Accompany Early Olfactory Loss?
Unexplained smell loss rarely appears in isolation in neurodegenerative disease. In Parkinson’s disease, olfactory dysfunction frequently co-occurs with constipation, which can precede motor symptoms by years. Individuals may also report sleep disturbances, including REM sleep behavior disorder (acting out dreams), mood changes like apathy or depression, and subtle cognitive slowing.
The presence of multiple non-motor symptoms alongside smell loss raises the clinical concern significantly. In Alzheimer’s disease, early smell dysfunction may accompany subtle memory changes that the person themselves downplays—difficulty recalling recent conversations, mild difficulty with complex tasks—but objective cognitive testing may still appear normal. A common warning sign that families miss is when a person with smell loss also shows reduced motivation, loss of interest in activities, or significant mood changes. These combinations suggest underlying neurochemical changes and warrant neurological evaluation rather than dismissal as normal aging.
What Is the Timeline Between Olfactory Loss and Noticeable Symptoms?
The gap between smell loss and other clinical symptoms can range from zero years to more than a decade. In some individuals, olfactory dysfunction and motor or cognitive symptoms emerge around the same time, suggesting that disease processes are relatively advanced. In others—and this is where smell testing may have diagnostic value—smell loss appears years or even a decade before memory loss or movement problems become obvious.
Case studies of research participants followed longitudinally show that a subset of cognitively normal older adults with poor smell identification scores develop mild cognitive impairment or dementia within 5 to 10 years at rates higher than their age-matched peers with normal smell. For Parkinson’s disease, some individuals report retrospectively that they noticed smell loss 5 to 15 years before their first tremor. This lag time reflects the progression of alpha-synuclein pathology through the nervous system. Earlier detection of such changes could theoretically allow for earlier intervention, though currently no disease-modifying treatments can be reliably started based on smell loss alone.
When Should Someone Seek Medical Evaluation for Smell Loss?
Evaluation is particularly warranted if smell loss is unexplained (not following a head cold or obvious sinus disease), progressive over weeks to months, accompanied by other neurological symptoms, or occurring in someone with a family history of Parkinson’s or Alzheimer’s disease. An individual over 50 with new-onset smell loss and constipation, or someone of any age with smell loss plus movement changes like reduced arm swing or balance difficulty, should see a neurologist.
A middle-aged person with smell loss, REM sleep behavior disorder, and subtle mood changes merits comprehensive evaluation. Conversely, smell loss following an acute upper respiratory infection or present in the context of active sinusitis, allergies, or nasal polyps may resolve with treatment and does not typically indicate degenerative brain disease. The distinction often lies in the pattern: sudden smell loss during an illness is likely reversible; gradual, progressive smell loss without clear cause is more concerning and deserves medical attention.
Frequently Asked Questions
Can you regain your sense of smell if it’s due to a neurodegenerative disease?
If olfactory loss is caused by underlying neurodegeneration, it typically does not improve and often worsens over time. However, if smell loss results from sinusitis, allergies, or infection, treatment may restore function. This is why identifying the cause is clinically important.
Is smell loss always an early sign of Parkinson’s or Alzheimer’s?
No. Many people with smell loss never develop these diseases. Smell loss is common in aging, sinus disease, and after head injury. However, when olfactory dysfunction appears alongside other unexplained neurological symptoms or in someone with strong family history, it warrants evaluation.
Should everyone over 50 get a smell test as a screening tool?
Current medical guidelines do not recommend universal olfactory screening in asymptomatic older adults. However, olfactory testing is valuable for individuals with unexplained smell loss or early signs of neurological disease to help with diagnosis and staging.
Can medications cause smell loss?
Yes. Certain medications, including some blood pressure drugs, chemotherapy agents, and others, can affect smell. If smell loss coincides with starting a new medication, discussing this with a healthcare provider is important.
Does COVID-19-related smell loss indicate brain damage?
COVID-related olfactory loss typically results from viral damage to the olfactory epithelium (supporting cells and neurons in the nasal lining) rather than direct brain damage. Most people recover their sense of smell within weeks to months, though some experience prolonged dysfunction.
What research is ongoing related to smell loss and brain disease?
Multiple studies are investigating whether olfactory biomarkers can predict who will develop Parkinson’s or Alzheimer’s disease. Researchers are also exploring whether protecting or enhancing olfactory function through olfactory training or other interventions might delay symptom onset in at-risk individuals.
